I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Study on Efficacy and Safety of Low-Dose Apatinib Combined ..:
Wang KX
;
Cui TY
;
Yang XD
...
https://www.dovepress.com/study-on-efficacy-and-safety-of-low-dose-apatinib-combined-with-camrel-peer-reviewed-fulltext-article-OTT. , 2021
Link:
https://doaj.org/article/1920cf06adc944ccb14106092eae4..
RT Journal T1
Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1920cf06adc944ccb14106092eae468e&Exemplar=1&LAN=DE A1 Wang KX A1 Cui TY A1 Yang XD A1 Wang GQ A1 Jiang QS A1 Sun H A1 Jiang NY A1 Yong XM A1 Shi CB A1 Ding YB A1 Chen XF A1 Fang YY PB Dove Medical Press YR 2021 K1 clinical trial K1 agc/gejc K1 low-dose apatinib K1 camrelizumab K1 sox regimen K1 protocol K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.dovepress.com/study-on-efficacy-and-safety-of-low-dose-apatinib-combined-with-camrel-peer-reviewed-fulltext-article-OTT LK http://dx.doi.org/https://doaj.org/article/1920cf06adc944ccb14106092eae468e DO https://doaj.org/article/1920cf06adc944ccb14106092eae468e SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)